✦ LIBER ✦

Disparities in the treatment of patients with IL-2 for metastatic renal cell carcinoma

✍ Scribed by Christopher S. Saigal; Christopher M. Deibert; Julie Lai; Matthias Schonlau

Book ID: 116956396
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 165 KB
Volume: 28
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2008.09.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment selection for patients with me

Treatment selection for patients with metastatic renal cell carcinoma

✍ Michael B. Atkins; Toni K. Choueiri; Daniel Cho; Meredith Regan; Sabina Signoret 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Treatment selection for patients with me

Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapy

✍ Michael B. Atkins 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 192 KB

Pazopanib for the Treatment of Metastati

Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma

✍ Amy M. Pick; Kelly K. Nystrom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Sunitinib for the treatment of metastati

Sunitinib for the treatment of metastatic renal cell carcinoma

✍ Stéphane Oudard; Benoit Beuselinck; Jasper Decoene; Peter Albers 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Recombinant interleukin 2 for metastatic

Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients

✍ Buter, J.; Janssen, R.A.J.; Mulder, N.H.; de Jong, P.E.; de Leij, L.; Sleijfer, 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 265 KB

NEPHRECTOMY BEFORE INTERLEUKIN-2 THERAPY

NEPHRECTOMY BEFORE INTERLEUKIN-2 THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Fallick, Mark L.; McDermott, David F.; LaRock, Dennis; Long, John P.; Atkins, Mi 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 712 KB